» Articles » PMID: 24615601

The Role of Adrenal Scintigraphy in the Diagnosis of Subclinical Cushing's Syndrome and the Prediction of Post-surgical Hypoadrenalism

Overview
Journal World J Surg
Publisher Wiley
Specialty General Surgery
Date 2014 Mar 12
PMID 24615601
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Management of subclinical Cushing's syndrome (SCS) remains controversial; it is not possible to predict which patients would benefit from adrenalectomy. In the present study we aimed to evaluate the role of adrenocortical scintigraphy (ACS) in the management of patients with SCS.

Methods: The medical records of 33 consecutive patients with adrenal "incidentaloma" and proven or suspected SCS who underwent (131)I-19-iodocholesterol ACS between 2004 and 2010 were reviewed. Sixteen underwent laparoscopic adrenalectomy (surgical group-S-group) and 17 were medically managed (medical group-M-group). Follow-up evaluation was obtained by outpatient consultation.

Results: Overall 25 patients (15 in the S-group and 10 in the M-group) had concordant unilateral uptake at ACS (ACS+). In the S-group, the mean follow-up duration was 30.9 ± 16.1 months and, irrespective of the presence of hormonal diagnosis of SCS, in patients who were ACS+ adrenalectomy resulted in a significant increase in HDL cholesterol and decreases in body mass index, glycemia, and blood pressure (BP). One patient reduced antihypertensive medication and three others were able to discontinue it altogether. Prolonged postoperative hypoadrenalism (PH) occurred in 14 patients in the S-group. The overall accuracy in predicting PH was 93.7 % for ACS and 68.7 % for laboratory findings. In the M-group, the mean follow-up duration was 31.5 ± 26.3 months and no patient developed overt Cushing's syndrome, although ACS+ patients experienced a worsening in glycemia and diastolic BP.

Conclusions: Adrenal scintigraphy seems the most accurate diagnostic test for SCS. It is able to predict the metabolic outcome and the occurrence of PH, identifying the patients who could benefit from adrenalectomy irrespective of hormonal diagnosis.

Citing Articles

Comparison of adrenalectomy with conservative treatment on mild autonomous cortisol secretion: a systematic review and meta-analysis.

Khadembashiri M, Mohseni S, Harandi H, Pejman Sani M, Khadembashiri M, Atlasi R Front Endocrinol (Lausanne). 2024; 15:1374711.

PMID: 38808111 PMC: 11131104. DOI: 10.3389/fendo.2024.1374711.


Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion.

Araujo-Castro M, Minguez Ojeda C, Sanchez Ramirez M, Gomez Dos Santos V, Pascual-Corrrales E, Fernandez-Argueso M Endocrine. 2022; 78(1):142-150.

PMID: 35751779 DOI: 10.1007/s12020-022-03120-w.


The role of adrenal venous sampling (AVS) in primary bilateral macronodular adrenocortical hyperplasia (PBMAH): a study of 16 patients.

Rubinstein G, Osswald A, Braun L, Vogel F, Kroiss M, Pilz S Endocrine. 2022; 76(2):434-445.

PMID: 35274284 PMC: 9068666. DOI: 10.1007/s12020-022-03020-z.


Frequently asked questions and answers (if any) in patients with adrenal incidentaloma.

Ceccato F, Barbot M, Scaroni C, Boscaro M J Endocrinol Invest. 2021; 44(12):2749-2763.

PMID: 34160793 PMC: 8572215. DOI: 10.1007/s40618-021-01615-3.


Adrenal Vein Cortisol to Metanephrine Ratio for Localizing ACTH-Independent Cortisol-Producing Adenoma: A Case Report.

Raj R, Kern P, Ghanta N, Uy E, Asadipooya K J Endocr Soc. 2021; 5(4):bvab009.

PMID: 33644621 PMC: 7881758. DOI: 10.1210/jendso/bvab009.


References
1.
Chiodini I, Morelli V, Salcuni A, Eller-Vainicher C, Torlontano M, Coletti F . Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J Clin Endocrinol Metab. 2010; 95(6):2736-45. DOI: 10.1210/jc.2009-2387. View

2.
Ross N . Epidemiology of Cushing's syndrome and subclinical disease. Endocrinol Metab Clin North Am. 1994; 23(3):539-46. View

3.
Toniato A, Merante-Boschin I, Opocher G, Pelizzo M, Schiavi F, Ballotta E . Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Ann Surg. 2009; 249(3):388-91. DOI: 10.1097/SLA.0b013e31819a47d2. View

4.
Palmieri S, Morelli V, Polledri E, Fustinoni S, Mercadante R, Olgiati L . The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism. Eur J Endocrinol. 2012; 168(3):289-96. DOI: 10.1530/EJE-12-0803. View

5.
Tsuiki M, Tanabe A, Takagi S, Naruse M, Takano K . Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome. Endocr J. 2008; 55(4):737-45. DOI: 10.1507/endocrj.k07e-177. View